Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06074393
Other study ID # REB23-0949
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 19, 2023
Est. completion date October 31, 2024

Study information

Verified date October 2023
Source University of Calgary
Contact Veronica Bruno, MD, MPH
Phone 4032107542
Email veronica.bruno@ucalgary.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to understand how support groups can help people who care for individuals with Parkinson's Disease and Related Disorders (PDRD). The investigators want to find answers to these questions: - How do these support groups make caregivers feel? - Do these support groups help caregivers cope better and improve their quality of life? Participants in this study will join support groups where they can talk to other caregivers and learn from experts. These groups will meet every two weeks for four months, and there will be sessions on different topics like self-care, coping skills, and mindfulness. Caregivers will share their experiences and ask questions in these sessions. Information will be collected before and after the support group meetings using surveys. These surveys will help understand how the support groups affect caregivers. Things like caregiver burden, coping strategies, and overall well-being will be measured. The main goal is to reduce the burden on caregivers of people with PDRD and improve their quality of life. It is believed that these support groups can make a positive difference, and this study will help understand how they work.


Description:

Background & Rationale: Neurodegenerative diseases are projected to surpass cancer as the leading cause of death by 2030. Parkinson's disease prevalence in Canada was 170/100,000 in 2013/2014, and with an aging population, the number of Canadians over 40 with the disease will rise by 65% by 2030. Advanced stages of Parkinson's Disease and Related Disorders (PDRD) result in motor disability and complex non-motor symptoms, increasing demand for healthcare services. Care partners face challenges such as anxiety, managing treatments, and uncertainty, leading to negative lifestyle changes and reduced mental health. Care partners of PDRD must manage stressors that impact their health and well-being. Existing support groups mainly focus on disease management, and neglecting care partner challenges. These pilot support groups provide an avenue for emotional and informational support, addressing care partner burdens. Structured meetings offer practical tools, solutions, and guest speakers, enhancing support group content. Research Question & Objectives The study aims to establish and assess support groups tailored to PDRD care partners' needs with two main objectives: Creating a supportive environment through structured meetings. Evaluating support group effectiveness in enhancing coping, reducing burden, and improving quality of life. Methods: Study Design: The study is structured around the establishment of a supportive community for individuals caring for PDRD. The primary objective is to foster connections among caregivers, enabling them to exchange personal experiences and derive shared comfort from others who comprehend the challenges associated with these conditions. Participants engage in a secure and confidential environment, sharing narratives and insights that contribute to their collective knowledge of effective caregiving. Moreover, the support group incorporates dedicated sessions led by healthcare experts encompassing various disciplines, including physicians, nurses, psychologists, social workers, and spiritual advisors. These specialized sessions, each lasting 90 minutes, occur biweekly over a 16-week period. Hosted at the University of Calgary's Cumming School of Medicine in a hybrid structure by using Zoom as a method of assistance, these sessions occur twice annually, accentuating the recurrent and structured nature of the support group. In each week various themes will be addressed, such as: Self-care and Personal Health Adaptation to changes in the living situation, changing roles and navigating the system Coping skills and Resilience Emotions (embracing vulnerability, emotional identification, factual validation, counteraction, problem resolution). Anticipatory grief Forgiveness and interconnectedness Mindfulness Establishing boundaries, attaining tranquility, and achieving closure In every session of the support group, care partners are encouraged to participate by sharing their experiences, as well as asking pertinent questions. Data Collection: The study employs pre- and post-participation questionnaires and measurement instruments to assess support group efficacy comprehensively using Qualtrics as a data collection tool for the surveys. Instruments include: Short Zarit Burden Interview (ZBI-12) to quantify caregiving impact. Brief-COPE to assess coping mechanisms. Adult Carer Quality of Life Questionnaire (AC-QoL) to measure overall well-being. Satisfaction Survey to gather participant feedback and knowledge acquisition. Outcomes: Primary Outcomes: Care Partner Burden: Assessed using ZBI-12. Coping Strategies: Evaluated with Brief-COPE scale. Quality of Life: Scrutinized using AC-QoL scale. Secondary Outcomes: Satisfaction with Participation: Caregiver Support Group Satisfaction Survey The study addresses the increasing burden on care partners of individuals with PDRD. It establishes and evaluates support groups tailored to their needs to enhance coping, reduce burden, and improve quality of life. The study utilizes structured meetings, measurement instruments, and comprehensive assessments to shed light on the effects of the support groups on care partners' well-being.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date October 31, 2024
Est. primary completion date October 19, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Care partners of individuals with a confirmed diagnosis of Parkinsonian Syndrome. - Participants in the Calgary Movement Disorders Advanced Care pilot program (REB22-0545) Exclusion Criteria: - Care partners with significant cognitive impairments that hinder participation with MoCA<10 points.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Tailored Support Group
Participants engage in a secure, confidential environment, sharing caregiving insights and knowledge. Expert-led sessions, lasting 90 minutes, occur biweekly for 16 weeks, held via Zoom and at the University of Calgary's Cumming School of Medicine. These sessions take place twice annually, emphasizing the structured nature of the support group. Weekly themes include self-care, adaptation, coping skills, emotions, anticipatory grief, forgiveness, mindfulness, boundaries, and closure. Care partners actively participate by sharing experiences and asking questions in each session.

Locations

Country Name City State
Canada Health Science Centre, University of Calgary Calgary Alberta

Sponsors (1)

Lead Sponsor Collaborator
University of Calgary

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Care Partner Burden: Assessed using ZBI-12. ZBI-12 is validated as a screening tool for advanced illness. The ZBI-12 is rated on a 12 items scale, with the severity of burden using a range of responses from 0 to 4 points per item and a total score range of 0 to 48. Scoring 0-10 is considered as a no to mild burden; 10-20, a mild to moderate burden and >20, a high burden. It measures changes in physical, emotional, social, and financial problems that can be experienced by family caregivers. Enrollment and at the end of the Support Group. 1 and 16 weeks.
Primary Changes in Coping Strategies: Evaluated with Brief-COPE scale. The Brief COPE (Coping Orientation to Problems Experienced) scale, composed of 28 items, each rated on a 4-point scale where 3 represents the highest score, exhibits a minimum value of 0 and a maximum value of 84. When interpreting Brief COPE scores, higher values are indicative of a potentially enhanced capacity to navigate stress and handle challenging situations. These elevated scores reflect a greater propensity to employ diverse coping strategies when confronted with difficulties. Enrollment and at the end of the Support Group. 1 and 16 weeks.
Primary Changes in Quality of Life: Scrutinized using AC-QoL scale. The Adult Carer Quality of Life (AC-QoL) Scale encompasses both an overall scale and eight subscales. The overall scale yields scores ranging from 0 to 120, with higher scores signifying an enhanced quality of life for caregivers. Additionally, each of the eight subscales offers scores within a potential range of 0 to 15. Higher scores on these subscales indicate an improved quality of life for caregivers in specific domains pertaining to their caregiving responsibilities. This structured assessment provides valuable insights into the well-being of caregivers across multiple dimensions of their lives. Enrollment and at the end of the Support Group. 1 and 16 weeks.
Secondary Satisfaction with Participation: Caregiver Support Group Satisfaction Survey The Caregiver Support Group Satisfaction Survey is composed of a combination of six multiple-choice questions and three open-ended questions. Each of the six multiple-choice questions is evaluated on a scale ranging from 1 to 5, with 1 signifying the lowest level of satisfaction and 5 indicating the highest level of satisfaction. Consequently, the survey's maximum achievable score is 30, while the minimum score is 5. A higher score on this survey reflects an increased level of satisfaction with the support group, providing valuable feedback on the quality of support and services offered to caregivers. Byweekly for 16 weeks
See also
  Status Clinical Trial Phase
Completed NCT06037590 - A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops™ Relative to INBRIJA® Phase 1
Enrolling by invitation NCT04799418 - STEM-PD Open Label Extension (OLE) N/A
Completed NCT05699161 - Adipose-derived Stromal Vascular Fraction Cells to Treat Parkinson Phase 1/Phase 2
Not yet recruiting NCT05599659 - The Calgary Movement Disorders Advanced Care Pilot Program N/A
Completed NCT04140708 - Effects of Exercise on Glymphatic Functioning and Neurobehavioral Correlates in Parkinson's Disease N/A
Recruiting NCT03924414 - Trial of Parkinson's And Zoledronic Acid Phase 4
Recruiting NCT06203106 - NYSCF Scientific Discovery Biobank
Not yet recruiting NCT06400017 - Mechanism and Application of DBS in the Treatment of PD N/A
Recruiting NCT04797611 - STEM-Parkinson's Disease N/A
Not yet recruiting NCT06174948 - The Use of the CUE1 in People With Parkinson's Disease and Related Disorders N/A
Recruiting NCT05934747 - Aim 3 Particle Swarm Optimization PIGD N/A
Enrolling by invitation NCT04701177 - Digitally-enhanced, Decentralized, Multi-omics Observational Cohort
Recruiting NCT05962489 - Sleep-specific DBS Therapy in Parkinson's Disease N/A
Recruiting NCT05931692 - Virtual Reality and Fear of Falling in Parkinson's Disease
Recruiting NCT04468919 - Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit N/A
Completed NCT04925622 - Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
Recruiting NCT04214509 - LIPAD - LRRK2 International Parkinson's Disease Study
Active, not recruiting NCT05677633 - Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease Phase 1
Recruiting NCT06350617 - Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients N/A
Recruiting NCT06247423 - High-frequency Alternating Current Stimulation for Tremor in Parkinson's Disease. N/A